JuneBrain
Empowering eye care and neurology communities
Overview
Raised: $77,980
Rolling Commitments ($USD)
03/30/2023
$1,218
160
2019
Healthcare & Pharmaceuticals
HealthTech
B2B/B2C
Medium
High
Summary Profit and Loss Statement
FY 2021 | FY 2020 | |
---|---|---|
Revenue |
$0 |
$0 |
COGS |
$0 |
$0 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$139,921 |
$-96,495 |
Summary Balance Sheet
FY 2021 | FY 2020 | |
---|---|---|
Cash |
$231,098 |
$13,225 |
Accounts Receivable |
$0 |
$0 |
Total Assets |
$231,098 |
$13,225 |
Short-Term Debt |
$39,422 |
$61,477 |
Long-Term Debt |
$150,000 |
$50,000 |
Total Liabilities |
$189,422 |
$111,477 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Founder Profile
JuneBrain Founder Samantha Scott on Retinal Imaging
At 78.9 years, the average American’s life expectancy is way higher now than it was a century ago — 53.6 for men and 54.6 for women. It’s exciting that we can all make plans to enjoy life for at least a couple extra decades. Getting older isn’t all fun and games, though — it also means more time to develop a health condition, like a neurological or retinal disease.
JuneBrain knows how important it is to keep track of each individual’s health, and the company wants to make that easier to do. That’s why it developed a device called Neuro-i and a platform to help monitor patients’ neurological and retinal health in and out of the clinic. We reached out to founder and CEO Samantha Scott to hear about her own experience with a neurological condition and JuneBrain’s end goal.
Note: This interview was conducted over phone and email. It has been lightly edited for clarity and length.